The Plasma Fractionation market is a subset of the Blood Banking industry, which involves the collection, processing, and distribution of human blood and its components. Plasma fractionation is the process of separating plasma from whole blood, which is then used to produce a variety of therapeutic proteins and other products. These products are used to treat a variety of conditions, including hemophilia, immune deficiencies, and other rare diseases. Plasma fractionation also plays an important role in the production of vaccines and other biopharmaceuticals. The Plasma Fractionation market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
